Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol procedural sedation with ketamine versus alfentanil or remifentanil
NL-OMON29416Not yet recruiting
- Sponsor
- Catharina Ziekenhuis
- Start
- Sep 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of propofol, ketamine, alfentanil and remifentanil (3 arms), sponsored by Catharina Ziekenhuis. Primary endpoint: Physician satisfaction with the applied sedation technique. Planned start Sep 2014; status: not yet recruiting.
02
Drugs
propofolketaminealfentanilremifentanil
Beyond the preview
Go deeper on NL-OMON29416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29416.